These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 4403394

  • 1. [Cardiovascular agents. 9. Effects of 1-tert-butylamino-3-(O-tetrahydrofurfuryloxy) phenoxy)-2-propanol hydrochloride (Y-6124) on experimental arrhythmia in dogs].
    Nakanishi M, Imamura H, Nakamura T.
    Nihon Yakurigaku Zasshi; 1972 Mar; 68(2):240-53. PubMed ID: 4403394
    [No Abstract] [Full Text] [Related]

  • 2. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M, Cheymol G, Mouillé P, Gilbert JC, Schmitt H.
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract] [Full Text] [Related]

  • 3. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I, Hashimoto K, Katano Y, Tsukada T, Matsuda H.
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol.
    Flórez J, Arconada JA.
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):199-207. PubMed ID: 4396347
    [No Abstract] [Full Text] [Related]

  • 5. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG, Tay J.
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract] [Full Text] [Related]

  • 6. [Antiarrhythmic action of penbutolol].
    Boissier JR, Coutte R, Bertin MC, Giudicelli JF.
    Therapie; 1974 Feb; 29(2):261-9. PubMed ID: 4152641
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
    Nakanishi M, Imamura H, Nakamura T, Kimura T.
    Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of arrhythmias with practolol (Eraldin)].
    Van Durme JP, Bossaert L, Vermeire P, Pannier R.
    G Ital Cardiol; 1972 Apr; 2(1):161-2. PubMed ID: 4401034
    [No Abstract] [Full Text] [Related]

  • 11. [Antiarrhythmic effect of butidrine: experimental study on arrhythmias induced by N-adrenaline in halothane anesthesia].
    Rossano C, Romoli M, Brunozzi LT, Monti GB, Pavoni P.
    Acta Anaesthesiol; 1969 Apr; 20(4):663-700. PubMed ID: 4397385
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Use of pindolol (LB 46), a new beta-blockader in disorders of cardiac rhythm].
    Poletti T, Aquaro G.
    Minerva Cardioangiol; 1972 Apr; 20(7):402-18. PubMed ID: 4403233
    [No Abstract] [Full Text] [Related]

  • 14. [Studies on cardiovascular drugs. XII. Pharmacological properties of 1-tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol hydrochloride (Y-6124)].
    Imamura H, Nakamura T, Inui J, Yasuda H, Osuga K.
    Yakugaku Zasshi; 1972 Aug; 92(8):1039-51. PubMed ID: 4404839
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Anti-arrythmic effects of DL-propranolol, D-propranolol and I.C.I.50 172 in experimental myocardial infarction in dogs].
    Staszewska-Barczak J.
    Acta Physiol Pol; 1970 Aug; 21(3):317-29. PubMed ID: 4393011
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agent.
    Kaplan HR, Robson RD.
    J Pharmacol Exp Ther; 1970 Oct; 175(1):168-77. PubMed ID: 4394302
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.